Basic information about inhibitors

IPAD-DB ID	C00353
Name	JNJ-54861911
Category	Natural compounds
2D Structure
3D Structure
Molecular Formula	C 1 8 H 1 4 F N 5 O S
Molecular Weight	367.4 g/mol
IUPAC Name	N-[3-[(4S)-2-amino-4-methyl-1, 3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
InChI	InChI=1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8, 10H, 1H3, (H2, 21, 24)(H, 23, 25)/t18-/m0/s1
InChIKey	VLLFGVHGKLDDLW-SFHVURJKSA-N
Canonical SMILES	CC1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F
PubChem CID	68254185
DrugBank Accession Number	DB15307
CAS Registry Number	1200493-78-2

Biological activity data

Ki	-
EC50	-
IC50	9.8 nM(BACE-1)
Inhibition	-
Toxicity	-
ROS(reactive oxygen species)	-
Metal Chelating	-
BBB(blood-brain barrier)	-
Target Protein	β-site amyloid precursor protein cleaving enzyme 1 (BACE1)
Effects	-
Research Models	-
Main Source	-
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	367.4
Hac(Computed by SwissADME)	26
Volume(Computed by ADMETlab 2.0)	353.564
Density(Computed by ADMETlab 2.0)	1.038
nRing(Computed by ADMETlab 2.0)	3
MaxRing(Computed by ADMETlab 2.0)	6
nHet(Computed by ADMETlab 2.0)	8
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	21
Flexibility(Computed by ADMETlab 2.0)	0.19
Stero Centers(Computed by ADMETlab 2.0)	1
LogS(Computed by ADMETlab 2.0)	-3.582
LogD(Computed by ADMETlab 2.0)	2.455

ADMET properties

logP(Computed by ADMETlab 2.0)	2.73
TPSA(Computed by SwissADME)	129.46
Hbond Acceptor(Computed by SwissADME)	5
Hbond Donor(Computed by SwissADME)	2
Rotatable Bonds(Computed by SwissADME)

Pharmacokinetics

GI Absorption(Computed by SwissADME)	High
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	No
P-gp Substrate(Computed by SwissADME)	No
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	No
CYP2C9 Inhibitor(Computed by SwissADME)	Yes
CYP2D6 Inhibitor(Computed by SwissADME)	No
CYP3A4 Inhibitor(Computed by SwissADME)	Yes
log Kp(Skin Permeation)(Computed by SwissADME)	-7.14

Druglikeness

Lipinski(Computed by SwissADME)	0
Ghose(Computed by SwissADME)	0
Veber(Computed by SwissADME)	0
Egan(Computed by SwissADME)	0
Muegge(Computed by SwissADME)	0
Bioavailability Score(Computed by SwissADME)	0.55